Addition of Rituximab to BEACOPPescalated to Improve the Outcome of Early Interim PET Positive Advanced Stage Hodgkin Lymphoma Patients: Second Planned Interim Analysis of the HD18 Study.

被引:11
作者
Borchmann, Peter [1 ]
Haverkamp, Heinz [1 ]
Lohri, Andreas [2 ]
Kreissl, Stefanie [1 ]
Greil, Richard [3 ]
Markova, Jana [4 ]
Feuring-Buske, Michaela [5 ]
Meissner, Julia [6 ]
Duehrsen, Ulrich [7 ]
Engel, Nicole [8 ]
Keller, Ulrich [9 ]
Maschmeyer, Georg [10 ]
Dietlein, Markus [1 ]
Kobe, Carsten [1 ]
Fuchs, Michael [1 ]
Diehl, Volker [1 ]
Engert, Andreas [1 ]
机构
[1] Univ Hosp Cologne, Cologne, Germany
[2] Med Univ Clin, Liestal, Switzerland
[3] Hosp Salzburg, Salzburg, Austria
[4] Charles Univ Prague, Fac Med 3, Prague, Czech Republic
[5] Univ Ulm, D-89069 Ulm, Germany
[6] Univ Heidelberg Hosp, Heidelberg, Germany
[7] Univ Duisburg Essen, Univ Hosp Essen, Essen, Germany
[8] Univ Munich, Munich, Germany
[9] Tech Univ Munich, D-80290 Munich, Germany
[10] Ernst von Bergmann Hosp, Potsdam, Germany
关键词
D O I
10.1182/blood.V124.21.500.500
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
引用
收藏
页数:3
相关论文
empty
未找到相关数据